title: A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.
abstract: Chemokines displayed on the luminal surface of blood vessels play pivotal roles in inflammatory and homeostatic leukocyte trafficking in vivo. However, the mechanisms underlying the functional regulation of chemokines on the endothelial cell surface remain ill-defined. A promiscuous chemokine receptor, the Duffy antigen receptor for chemokines (DARC), has been implicated in the regulation of chemokine functions. Here we show that DARC is selectively expressed at the mRNA and protein levels in the high endothelial venules (HEV) of unstimulated lymph nodes (LN). To examine the biological significance of DARC expression in HEV, we performed competitive binding experiments with 20 different chemokines. The results showed that DARC selectively bound distinct members of the pro-inflammatory chemokines such as CXCL1, CXCL5, CCL2, CCL5 and CCL7, but not lymphoid chemokines such as CCL21, CCL19, CXCL12 and CXCL13 that are normally expressed in HEV. CCL2 bound to DARC failed to induce a significant cytosolic [Ca(2+)] elevation in CCR2B-expressing cells, whereas the free form of CCL2 induced a distinct [Ca(2+)] elevation, suggesting that DARC down-regulates activities of pro-inflammatory chemokines upon binding. Targeted disruption of the gene encoding DARC did not induce any obvious changes in the cell number or leukocyte subsets in the peripheral and mesenteric LN. Neither did DARC deficiency significantly affect lymphocyte migration into LN. These results suggest that DARC may be a scavenger for pro-inflammatory chemokines, but not a presenting molecule for lymphoid chemokines at HEV and that it is probably functionally dispensable for lymphocyte trafficking to HEV-bearing lymphoid tissues under physiological conditions.
mesh_terms: D000818:Animals; D051379:Mice; D001789:Blood Group Antigens; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000502:physiology; D018932:Chemokine CCL2 / Q000378:metabolism; D054421:Chemokine CCL21; D018925:Chemokines / Q000378:metabolism / Q000494:pharmacology; D019742:Chemokines, CC / Q000378:metabolism; D002634:Chemotaxis, Leukocyte; D016207:Cytokines / Q000096:biosynthesis; D004375:Duffy Blood-Group System; D004730:Endothelium, Vascular / Q000378:metabolism; D008198:Lymph Nodes / Q000098:blood supply / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D018345:Mice, Knockout; D011956:Receptors, Cell Surface / Q000096:biosynthesis / Q000378:metabolism; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors / Q000378:metabolism; D014699:Venules / Q000378:metabolism
chemical_list: D001789:Blood Group Antigens; D002118:Calcium; D015220:Calcium Channels; C515479:Ccl21c protein, mouse; D018932:Chemokine CCL2; D054421:Chemokine CCL21; D018925:Chemokines; D019742:Chemokines, CC; D016207:Cytokines; D004375:Duffy Blood-Group System; D011956:Receptors, Cell Surface; D019707:Receptors, Chemokine; C483025:Ackr1 protein mouse